Literature DB >> 16632112

Involvement of selenoprotein P in protection of human astrocytes from oxidative damage.

Holger Steinbrenner1, Lirija Alili, Esra Bilgic, Helmut Sies, Peter Brenneisen.   

Abstract

Selenoprotein P (SeP) is a highly glycosylated, selenium-rich plasma protein. Aside from its role as selenium carrier protein, an antioxidative function of SeP has been suggested. Astrocytes, which detoxify reactive oxygen species in the brain, were described as potential target cells of SeP. We investigated the expression of SeP in human astrocytes and its involvement in the protection of these cells against tert-butyl hydroperoxide (t-BHP)-induced oxidative damage. We show that primary human astrocytes and the human astrocytoma cell line MOG-G-CCM express SeP as an unglycosylated protein, which is not secreted. SeP expression in astrocytes is constitutive. Preincubation of astrocytes with hepatocyte-derived SeP mimicks the protective effect of low-molecular-weight selenocompounds such as sodium selenite or selenomethionine against oxidative damage, shielding astrocytes from t-BHP-induced cytotoxicity. Selenium supplementation of astrocytes counteracts oxidative stress via an increase in expression and activity of the selenoenzyme cytosolic glutathione peroxidase (cGPx). Furthermore, specific downregulation of SeP expression by small interfering RNA decreases cell viability of human astrocytes and makes them more susceptible to t-BHP-induced cytotoxicity. Our results implicate an antioxidant activity of constitutively expressed SeP in selenium-deficient astrocytes, while during adequate selenium supply the enhanced protection against oxidative stress is exerted by cGPx.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632112     DOI: 10.1016/j.freeradbiomed.2005.12.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  39 in total

1.  Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats.

Authors:  Seema Panicker; S S Swathy; Febi John; Indira M
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Selenium: its role as antioxidant in human health.

Authors:  Ujang Tinggi
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

3.  Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children.

Authors:  B-J Ko; S M Kim; K H Park; H S Park; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2014-03-18       Impact factor: 5.095

4.  Using saccades to diagnose covert hepatic encephalopathy.

Authors:  Nicholas Cunniffe; Henry Munby; Shona Chan; Defne Saatci; Eric Edison; R H S Carpenter; Dunecan Massey
Journal:  Metab Brain Dis       Date:  2015-01-15       Impact factor: 3.584

5.  Sepp1(UF) forms are N-terminal selenoprotein P truncations that have peroxidase activity when coupled with thioredoxin reductase-1.

Authors:  Suguru Kurokawa; Sofi Eriksson; Kristie L Rose; Sen Wu; Amy K Motley; Salisha Hill; Virginia P Winfrey; W Hayes McDonald; Mario R Capecchi; John F Atkins; Elias S J Arnér; Kristina E Hill; Raymond F Burk
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

6.  Association of selenoprotein p with Alzheimer's pathology in human cortex.

Authors:  Frederick P Bellinger; Qing-Ping He; Miyoko T Bellinger; Yanling Lin; Arjun V Raman; Lon R White; Marla J Berry
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

7.  Selenoprotein T Deficiency Leads to Neurodevelopmental Abnormalities and Hyperactive Behavior in Mice.

Authors:  Matthieu T Castex; Arnaud Arabo; Magalie Bénard; Vincent Roy; Vadim Le Joncour; Gaëtan Prévost; Jean-Jacques Bonnet; Youssef Anouar; Anthony Falluel-Morel
Journal:  Mol Neurobiol       Date:  2015-10-26       Impact factor: 5.590

8.  Expression and regulation of mouse selenoprotein P transcript variants differing in non-coding RNA.

Authors:  Andrea S T Dewing; Rachel H Rueli; Michael J Robles; Elizabeth D Nguyen-Wu; Thomas Zeyda; Marla J Berry; Frederick P Bellinger
Journal:  RNA Biol       Date:  2012-10-12       Impact factor: 4.652

Review 9.  Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Authors:  Pin Zhuo; Alan M Diamond
Journal:  Biochim Biophys Acta       Date:  2009-03-13

Review 10.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.